Parameters derived from the postoperative decline in ultrasensitive PSA improve the prediction of radical prostatectomy outcome

World Journal of Urology

Volumn 31, Issue 2, 2013, Pages 299-304

  Vesely, Stepan ^a   Jarolim, Ladislav ^a   Schmidt, Marek ^a   Minarik, Ivo ^a   Dusek, Pavel ^a   Babjuk, Marko ^a  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

Prognosis; Prostate cancer; PSA; Radical prostatectomy

Indexed keywords

EID: 84876673894     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-012-0892-3     Document Type: Article

References (20)

1. Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC (1999) Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281: 1591-1597.
2. Chun FK, Graefen M, Zacharias M, Haese A, Steuber T, Schlomm T, Walz J, Karakiewicz PI, Huland H (2006) Anatomic radical retropubic prostatectomy-long-term recurrence-free survival rates for localized prostate cancer. World J Urol 24: 273-280.
3. Simmons MN, Stephenson AJ, Klein EA (2007) Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy. Eur Urol 51(5): 1175-1184.
4. Siddiqui SA, Boorjian SA, Inman B, Bagniewski S, Bergstralh EJ, Blute ML (2008) Timing of androgen deprivation therapy and its impact on survival after radical prostatectomy: a matched cohort study. J Urol 179(5): 1830-1837.
5. Gomella LG, Zeltser I, Valicenti RK (2003) Use of neoadjuvant and adjuvant therapy to prevent or delay recurrence of prostate cancer in patients undergoing surgical treatment for prostate cancer. Urology 62(1): 46-54.
6. Lugghezani G, Briganti A, Karakiewicz PI, Kattan MW, Montorsi F, Shariat SF, Vickers AJ (2010) Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature. Eur Urol 58(5): 687-700.
7. Walz J, Chun FKH, Klein EA, Reuther A, Graefen M, Huland H, Karakiewicz PI (2009) Risk-adjusted hazard rates of biochemical recurrence for prostate cancer patients after radical prostatectomy. Eur Urol 55(2): 412-419.
8. Freedland SJ, Humphreys EB, Mangold LA, Eisenberger M, Dorey FJ, Walsh PC, Partin AW (2005) Risk of prostate cancer mortality following biochemical recurrence after radical prostatectomy. JAMA 294: 433-439.
9. Cowen ME, Halasyamani LK, Kattan MV (2006) Predicting life expectancy in men with clinically localized prostate cancer. J Urol 175: 99-103.
10. Stephenson AJ, Scardino PT, Eastham JA, Bianco FJ, Dotan ZA, DiBlasio CJ, Reuther A, Klein EA, Kattan MW (2005) Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol 23: 7005-7012.
11. Shariat SF, Karam JA, Walz J, Roehrborn CG, Montorsi F, Margulis V, Saad F, Slawin KM, Karakiewicz PI (2008) Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers. Clin Cancer Res 14(12): 3785-3791.
12. Semjonow A, Hamm M, Rathert P (1993) Prediction of tumor recurrence after radical prostatectomy using elimination kinetics of prostate-specific antigen. World J Urol 11(4): 218-220.
13. Shen S, Lepor H, Yaffee R, Taneja SS (2005) Ultrasensitive serum prostate specific antigen nadir accurately predicts the risk of early relapse after radical prostatectomy. J Urol 173(3): 777-780.
14. Eisenberg ML, Davies BJ, Cooperberg MR, Cowan JE, Carroll PR (2010) Prognostic implications of an undetectable ultrasensitive prostate-specific antigen level after radical prostatectomy. Eur Urol 57(4): 622-629.
15. Epstein JI, Allsbrook WC Jr, Amin MB, Egevald LL, ISUP grading committee (2005) The 2005 international society of urologic pathology (ISUP) Consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol 29: 1228-1242.
16. DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44: 837-845.
17. Doherty AP, Bower M, Smith GL, Miano R, Mannion EM, Mitchell H, Christmas TJ (2000) Undetectable ultrasensitive PSA after radical prostatectomy for prostate cancer predicts relapse-free survival. Br J Cancer 83(11): 1432-1436.
18. Hong SK, Park HZ, Lee WK, Kim DS, Lee JS, Doo SH, Jeong SJ, Yoon CY, Byun SS, Lee SE (2010) Prognostic significance of undetectable ultrasensitive prostate-specific antigen nadir after radical prostatectomy. Urology 76(3): 723-727.
19. Haese A, Huland E, Graefen M, Hammerer P, Noldus J, Huland H (1999) Ultrasensitive detection of prostate specific antigen in the followup of 422 patients after radical prostatectomy. J Urol 161(4): 1206-1211.
20. Amling CL, Blute ML, Bergstralh EJ, Seay TM, Slezak J, Zincke H (2000) Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years. J Urol 164: 101-105.